Multiple listing for pediatric heart transplantation in the U.S.A.: analysis of OPTN registry data from 1995 through 2009

Pediatr Transplant. 2013 Dec;17(8):787-93. doi: 10.1111/petr.12162. Epub 2013 Sep 30.

Abstract

Multiple listing is associated with shorter waitlist durations and increased likelihood of transplantation for renal candidates. Little is known about multiple listing in pediatric heart transplantation. We examined the prevalence and outcomes of multiple listing using OPTN data from 1995 through 2009. Characteristics and waitlist outcomes of propensity-score-matched single- and multiple-listed patients were compared. Multiple listing occurred in 23 of 6290 listings (0.4%). Median days between listings was 35 (0-1015) and median duration of multiple listings was 32 days (3-363). Among multiple-listed patients, there were trends toward less ECMO use (0% vs. 11%, p = 0.1) and more frequent requirement for a prospective cross-match (17% vs. 8%, p = 0.08). Multiple-listed patients more commonly had private insurance (78% vs. 56%; p = 0.03). Urgency status at listing was similar between groups (1/1A: 61% vs. 64%, 1B/2: 39 vs. 36%; p = 0.45) as were weight, age, diagnosis, ventilator/inotrope use, and median income (each p ≥ 0.17). There was a trend toward increased incidence of heart transplantation for multiple-listed patients at three, six, and 24 months (50%, 65%, 80%) vs. single-listed patients (40%, 54%, 64%; p = 0.11). Multiple listing for pediatric heart transplantation in the USA occurs infrequently and is more common in patients with private insurance.

Keywords: Organ Procurement and Transplantation Network; pediatric heart transplant; socioeconomic factors; waitlist mortality.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Blood Grouping and Crossmatching
  • Child
  • Child, Preschool
  • Data Collection
  • Data Interpretation, Statistical
  • Female
  • Heart Failure / epidemiology
  • Heart Failure / therapy*
  • Heart Transplantation / standards*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Insurance, Health
  • Male
  • Prevalence
  • Registries*
  • Social Class
  • Time Factors
  • Tissue and Organ Procurement / methods*
  • Treatment Outcome
  • United States
  • Waiting Lists*